PT  - JOURNAL ARTICLE
AU  - Brum, Arthur A.
AU  - Vasconcelos, Giovani L.
AU  - Duarte-Filho, Gerson C.
AU  - Ospina, Raydonal
AU  - Almeida, Francisco A. G.
AU  - Macêdo, Antônio M. S.
TI  - Modinterv COVID-19: An online platform to monitor the evolution of epidemic curves
AID  - 10.1101/2022.01.31.22270192
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.01.31.22270192
4099  - http://medrxiv.org/content/early/2022/02/06/2022.01.31.22270192.short
4100  - http://medrxiv.org/content/early/2022/02/06/2022.01.31.22270192.full
AB  - Background The COVID-19 pandemic is one of the worst public health crises the world has ever faced. A major hindrance in making apt decisions by health control systems is the fact that protocols tested in other epidemics are no guarantee of success to control the COVID-19 epidemic, given its singular nature and complexity. The occurrence of two or more waves of infections all over the world poses an even greater challenge. An effective way to assist health authorities in adopting public policies to face the COVID-19 pandemic depends on smart analytics and visualization.Purpose We present the software Modinterv as a tool to monitor, in an automated and user-friendly manner, the evolution and trend of COVID-19 epidemic curves, both for cases and deaths.Methods The Modinterv software uses parametric generalized growth models, together with machine learning algorithms, to fit epidemic curves with one or two waves of infections of cases and deaths for countries around the world as well as for states and cities in Brazil and the USA. The richness of the implemented models lies in the possibility of detecting the distinct acceleration regimes of the disease in places where there are one or two waves of infections.Results We show how growth models can be combined with machine learning algorithms in an automated software that can identify the current stage of the COVID-19 epidemic curve in the selected place. We describe the backend structure of software as well as its practical use. The software helps the user not only to understand the current stage of the epidemic in the chosen location but also to make short term predictions as to how the curves may evolve.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe gratefully acknowledge partial financial support from CNPq and CAPES Brazil.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesJohns Hopkins University https://coronavirus.jhu.edu/map.html and GitHub database maintained by Wesley Cota https://github.com/wcota/covid19br